Lifestyle Intervention to Improve Muscle Function in Older Adults
2026年9月1日 更新者:Candida Rebello、Pennington Biomedical Research Center
The goal of this randomized controlled two-arm trial is to determine the effect of a diet and exercise intervention for 12 weeks on body composition, muscle function, and energy balance in 80 adults aged 50 years and over with obesity and insulin resistance.
The main questions the trial aims to answer are: Will 12 weeks of a structured nutrition plan + exercise reduce fat mass, improve muscle function, and increase energy deficit compared to the usual diet + exercise.
The hypothesis is that 12 weeks of a structured nutrition plan + exercise will reduce fat mass, improve muscle function, and produce greater energy deficit than the usual diet + exercise.
Participants will be provided with all meals for 12 weeks and will exercise at the Center under supervision three times each week.
Pre and post-intervention, body composition, physical function, and energy deficit will be measured.
研究概览
地位
招聘中
详细说明
In the United States nearly one third of adults over 60 years of age have sarcopenic obesity which encompasses the combined effect of muscle impairment and obesity.
A strategy that addresses the combined effect of muscle impairment and obesity while modulating muscle mass and composition is an unanswered challenge.
This 12-week study will evaluate the effects of a structured nutrition plan combined with an exercise program on body fat and muscle mass, lower-extremity function (Short Physical Performance Battery), muscle strength (handgrip and knee strength), and daily caloric intake.
The study will enroll adults aged 50 years and older with obesity (body mass index ≥ 30 kg/m²) and insulin resistance as indicated by a homeostasis model assessment of insulin resistance (HOMA-IR) score ≥ 3. Subjects will be randomly allocated to receive the structured nutrition plan and exercise intervention or to their usual diet and exercise in equal numbers (40 per group).
The study will enrich our understanding of the physiological adaptations necessary for effective lifestyle interventions to improve muscle function.
研究类型
介入性
注册 (估计的)
80
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Candida J Rebello, PhD, RD
- 电话号码:12257633159
- 邮箱:Candida.Rebello@pbrc.edu
研究联系人备份
- 姓名:Reilly Roberts A Project Manager, MS
- 电话号码:225-763-2854
- 邮箱:candidajoan@hotmail.com
学习地点
-
-
Louisiana
-
Baton Rouge、Louisiana、美国、70808
- 招聘中
- Pennington Biomedical Research Center
-
接触:
- Candida J Rebello, PhD, RD
- 电话号码:225-763-3159
- 邮箱:Candida.Rebello@pbrc.edu
-
接触:
- Reilly Roberts A Project Manager, MS
- 电话号码:225-763-2854
- 邮箱:Reilly.Roberts@pbrc.edu
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Age > 50 years.
- Body mass index (BMI) ≥ 30 kg/m2.
- Homeostatic model assessment of insulin resistance ≥ 3.
- Mini-Mental State Examination (MMSE) > 25.
- Geriatric Depression Scale-15 (GDS-15) < 9.
- Sedentary (less than 90 minutes/week of moderate to vigorous activity).
- Ability to provide written informed consent.
Exclusion Criteria:
- Diagnosis of cancer (received within five years) or diabetes (type 1 and 2), or significant musculoskeletal, or cardiovascular, or hepatic, or renal, disease or dysfunction.
- Clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, celiac disease, or clinically significant abnormal laboratory markers.
- Fluctuation in body weight > 3 kg in the preceding two months
- Condition that impedes testing of the study hypothesis or makes it unsafe to exercise or consume the study foods.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Structured nutrition plan + exercise
Intervention: Participants receive a structured nutrition plan, and exercise under supervision.
|
Participants will receive a structured nutrition plan.
Participants will complete aerobic and resistance training under supervision three times per week.
|
|
有源比较器:Typical or usual diet + exercise
Participants receive a typical or usual diet, and exercise under supervision
|
Participants will complete aerobic and resistance training under supervision three times per week.
Participants will receive a diet representing the usual diet in this population.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Fat mass
大体时间:Change from baseline to 12 weeks
|
Fat mass measured by dual X-ray absorptiometry
|
Change from baseline to 12 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Skeletal muscle mass
大体时间:Change in from baseline to 12 weeks
|
Skeletal muscle mass will be measured by the creatine methyl D-3 dilution method
|
Change in from baseline to 12 weeks
|
|
Short physical performance battery
大体时间:Change from baseline to 12 weeks
|
A test of physical function
|
Change from baseline to 12 weeks
|
|
Hand-grip strength
大体时间:Change from baseline to 12 weeks
|
Hand grip strength will be measured using a hand dynamometer
|
Change from baseline to 12 weeks
|
|
Knee strength
大体时间:Change from baseline to12 weeks
|
Knee strength will be measured quantified using Biodex dynamometry
|
Change from baseline to12 weeks
|
|
Energy stores
大体时间:12 weeks
|
Change in energy stores/day (kcal) determined from measures of body composition using the energy balance method
|
12 weeks
|
|
Hormonal regulation of energy balance
大体时间:Change from baseline to 12 weeks
|
Blood concentrations of glucagon-like peptide 1
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
大体时间:Change from baseline to 12 weeks
|
Blood concentrations of gastric inhibitory peptide
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
大体时间:Change from baseline to 12 weeks
|
Blood concentrations of cortisol
|
Change from baseline to 12 weeks
|
|
Hormonal regulation of energy balance
大体时间:Change from baseline to 12 weeks
|
Blood concentrations of leptin
|
Change from baseline to 12 weeks
|
|
Cardiorespiratory fitness
大体时间:Change in VO2max from baseline to 12 weeks
|
VO2max
|
Change in VO2max from baseline to 12 weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Candida J Rebello, PhD, RD、Pennington Biomedical Research Center
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2026年7月20日
初级完成 (估计的)
2030年12月1日
研究完成 (估计的)
2030年12月1日
研究注册日期
首次提交
2026年5月8日
首先提交符合 QC 标准的
2026年5月14日
首次发布 (实际的)
2026年5月20日
研究记录更新
最后更新发布 (实际的)
2026年9月3日
上次提交的符合 QC 标准的更新
2026年9月1日
最后验证
2026年7月1日
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- PBRC-2025-060
- 1R01AG092725-01A1 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
IPD 计划说明
At this time, we do not have plans to share IPD.
We may consider it after the study results have been publicly disseminated
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.